SOD1 and acute respiratory distress syndrome: Antcin A treatment suppressed liver injury, decreased the ALT and AST levels (Figure 4A, 4B), reduced the expression of inflammatory factors (Figure 4C–4E), elevated SOD and GSH-Px levels, and decreased MDA level (Figure 4F–4H) dose-dependently, and the differences were significant relative to ALI group.